Moneta Health Secures $4.5M to Expand AI-Powered Cognitive Rehab Access Through New Partnership with Benefis Health System
Moneta Health, a pioneering brain health company leveraging artificial intelligence to deliver accessible, evidence-based cognitive rehabilitation therapy, has announced a $4.5 million funding round and a strategic multi-year partnership with Benefis Health System in Montana. The dual milestones mark a significant step forward in the company’s mission to bring high-quality cognitive care to “neurology deserts”—regions across the U.S. where access to neurologists and specialized brain health services is severely limited.
The investment was led by prominent venture capital firms including True Ventures and Health2047, the American Medical Association’s innovation and venture studio, with additional participation from Impact America Fund, BKR Capital, Koru, the Ontario Teachers’ Pension Plan, and the Centre for Aging + Brain Health Innovation (CABHI). This latest round follows Moneta’s $2.2 million pre-seed raise in March 2023, also led by True Ventures, underscoring strong investor confidence in the company’s vision and execution.
Cognitive impairment affects an estimated 32% of adults over the age of 65—a staggering 250 million people globally. Despite the prevalence of conditions like mild cognitive impairment (MCI) and early-stage dementia, access to effective treatment remains critically limited. Many patients are told there are few options beyond medication or monitoring, even though behavioral interventions like cognitive rehabilitation therapy (CRT) have been clinically proven to slow cognitive decline, improve daily functioning, and help individuals maintain independence longer.
“Cognitive rehabilitation therapy is like physical therapy for the brain,” explains Dr. Jen Flexman, co-founder and Chief Clinical Officer of Moneta Health. “It’s a structured, evidence-based approach that retrains cognitive skills through personalized exercises and therapist guidance. Yet fewer than 20% of eligible patients receive this care in outpatient settings—often due to geographic, technological, or financial barriers.”
Moneta’s solution directly addresses these gaps. The company’s platform combines human expertise with AI-driven support to deliver therapy entirely over the phone—no smartphone, internet connection, or app required. Patients work one-on-one with licensed cognitive therapists during scheduled calls and complete tailored cognitive exercises between sessions with Moneta’s AI-powered therapy assistant, which adapts in real time based on performance and engagement. This low-tech, high-touch model ensures accessibility for older adults and those in rural or underserved communities who may lack digital literacy or reliable broadband.
The clinical efficacy of Moneta’s program has been validated in real-world settings. At the recent Alzheimer’s Association International Conference (AAIC) in Toronto, the company presented outcomes showing that patients enrolled in its program improved their cognitive function by an average of 18% over the course of treatment—surpassing the U.S. national benchmark of 13% for traditional outpatient cognitive therapy.
“For me, this work is deeply personal,” said Paul A. Campbell, co-founder and CEO of Moneta Health. “My mother was diagnosed with dementia in 2017. I watched her struggle, and I wish we’d had a platform like Moneta earlier in our journey—one that could have helped preserve her cognitive abilities and quality of life for longer. That experience fuels our mission every day.”
The new partnership with Benefis Health System—a leading integrated healthcare provider serving central Montana—will integrate Moneta’s cognitive rehab program into Benefis’s healthy aging care pathway. Montana, home to the sixth-oldest population in the U.S., faces significant challenges in accessing neurology care, with vast distances between communities and a shortage of specialists. Moneta’s phone-based model offers a practical, scalable solution.
“We are excited to partner with Moneta to make personalized, evidence-based cognitive rehabilitation the standard of care for our patients and families,” said Dr. Greg Tierney, President of System Clinical Operations at Benefis Health System. “Moneta’s proven program is an accessible approach to proactive brain health for our aging demographic, and it aligns perfectly with our commitment to whole-person, community-centered care.”
The $4.5 million investment will accelerate Moneta’s product development, expand its clinical research initiatives, and support geographic growth into additional underserved regions. The company currently operates a virtual clinic serving patients in Florida, Nevada, Washington, and West Virginia, with plans for nationwide expansion. Critically, Moneta’s services are reimbursable under Medicare, TRICARE, and a growing number of Medicare Advantage plans—including Aetna, Blue Cross Blue Shield, Humana, OPTUM, and Sunshine Health—making the therapy financially accessible to the populations who need it most.
Investors highlight Moneta’s unique ability to bridge clinical rigor with scalable delivery. “Physicians everywhere are struggling to find effective, scalable solutions for patients with complex cognitive needs, particularly in regions with few or no neurologists,” said Lawrence K. Cohen, PhD, CEO of Health2047. “Moneta’s model brings clinically proven therapy directly to patients’ homes, giving physicians a new, practical tool to address this critical gap in care.”
True Ventures, which backed Moneta from its earliest days, reaffirmed its belief in the founding team. “Moneta is the second time we’ve invested in a company founded by Paul,” said Phil Black, co-founding partner at True Ventures. “The company is solving an important problem in a growing market that touches so many lives—families, clinicians, payers, and communities alike.”
As the U.S. grapples with a rapidly aging population and rising rates of dementia—projected to affect nearly 14 million Americans by 2060—innovative care models like Moneta’s are not just valuable, they are essential. Traditional care systems are ill-equipped to meet the coming wave of demand, particularly outside major metropolitan areas. Moneta’s approach reimagines cognitive therapy as a proactive, preventive, and widely accessible service—delivered with dignity, simplicity, and scientific integrity.
Looking ahead, Moneta is actively building partnerships with additional health systems, insurance payers, and community-based organizations across the country. The company envisions a future where cognitive rehabilitation is as routine as cardiac rehab or physical therapy—a standard component of healthy aging and chronic disease management.
With strong clinical outcomes, a scalable delivery model, strategic investor backing, and a growing footprint in high-need regions, Moneta Health is positioned to lead a transformation in brain health care. By meeting patients where they are—literally and technologically—the company is turning the promise of accessible, effective cognitive therapy into a reality for millions.
